Oncology & Cancer

Finally, targeted therapies for triple-negative breast cancer

At the American Society for Clinical Oncology (ASCO) Annual Meeting 2016, researchers present results of three clinical trials using new targeted therapies against triple negative breast cancer (TNBC). Each therapy uses a ...

Oncology & Cancer

Brain cancer growth halted by absence of protein, study finds

The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain's nerve cells, according to a new study by researchers at the Stanford University School ...

Oncology & Cancer

Non-coding portions of genome are found to play role in cancer

The human body produces 100,000 or more different proteins. Yet, amazingly, only two percent of the human genome actually encodes proteins. Nearly 80 percent of the rest of the genome is transcribed into RNA that does not ...

Oncology & Cancer

'Lock-'n'-block' drug may prevent cancer from metastasizing

"They got all of it" are the reassuring words people hope to hear following cancer surgery, but a growing understanding of the science of how cancer spreads, and metastasizes, is suggesting that not only is this almost never ...

page 1 from 23